GHK-Cu for hair growth: what the evidence actually shows

What's this video probably claiming?

This TikTok, posted by @swepeptide with a before-and-after format, is almost certainly showing visible hair density or thickness changes attributed to GHK-Cu (copper tripeptide-1) use over time. The caption translates roughly from Swedish as 'Before and after with GHK-Cu. Not a miracle, but clear improvement over time. Patience and consistency is everything.' That framing is deliberately modest, which actually makes it more persuasive, not less. The creator is likely arguing that topical or injectable GHK-Cu produced measurable hair regrowth with consistent use over weeks or months. The hashtags reinforce this: hårresa means 'hair journey' in Swedish, and the combination with hairgrowth and peptide signals this is positioned as a cosmetic-to-medical crossover claim. The 125K views suggest this lands with a Scandinavian and broader European peptide-curious audience who are skeptical of mainstream treatments but open to biohacking alternatives.

What does the science actually show?

GHK-Cu is a naturally occurring copper-binding tripeptide. It has real biological activity. That part is not in dispute. Studies have shown it can stimulate hair follicle proliferation in vitro. Uno et al. (1993, Journal of Investigative Dermatology) found that copper peptides increased hair follicle size and prolonged the anagen growth phase in animal models. A more recent review by Pickart and Margolina (2018, Biomolecules) summarized GHK-Cu's role in upregulating growth factors including VEGF and KGF, both relevant to follicle function. However, the jump from 'stimulates follicles in a lab dish' to 'regrows your hair' is enormous. There is no large-scale, double-blind, placebo-controlled human trial demonstrating that GHK-Cu, topical or injectable, produces statistically significant hair regrowth comparable to minoxidil or finasteride. One small comparative study (Arias et al., 2000) suggested copper peptides showed results similar to 5% minoxidil in a limited cohort, but the sample sizes were too small to draw firm conclusions.

Where does the social media noise diverge from clinical reality?

Before-and-after videos are the single most effective, and most misleading, format in the wellness content economy. Hair density changes dramatically with lighting angle, camera settings, hair washing status, and even the time of day photos are taken. Nobody on TikTok is controlling for those variables. Beyond the photography problem, GHK-Cu use in hair applications spans wildly different delivery methods: topical serums, microneedling co-applications, and injectable peptide protocols. These are not equivalent interventions. The concentration of GHK-Cu in over-the-counter cosmetics is typically far below what was used in the limited studies showing any effect. Injectable GHK-Cu, which some peptide communities use, exists in a completely different regulatory and pharmacokinetic category. Conflating a 2% serum from a cosmetics brand with a compounded injectable peptide protocol is a significant accuracy problem. Social media also systematically underreports non-responders. For every 125K-view success video, there are thousands of people who saw nothing.

What should you actually know?

GHK-Cu is a genuinely interesting compound with a reasonable mechanistic basis for potential hair and skin benefits. The preclinical data is real. But the clinical evidence in humans is thin, particularly for hair regrowth as a primary outcome. If you are experiencing hair loss significant enough to consider peptide therapy, the starting point should be identifying the cause, androgenetic alopecia, telogen effluvium, nutritional deficiency, and autoimmune conditions all require different approaches. Minoxidil and finasteride have decades of controlled trial data behind them. GHK-Cu does not. That does not make GHK-Cu worthless, but it means you should not substitute it for established treatments based on a TikTok before-and-after. If you are considering peptide protocols involving injectable compounds, that conversation belongs in a clinical setting with a licensed provider who can assess your specific situation, not in a comment section.